Featured Research

from universities, journals, and other organizations

Patients with kidney failure to get a new lease on life

Date:
April 14, 2014
Source:
European Commission, CORDIS
Summary:
A European research consortium has been developing a wearable artificial kidney that would make it possible for dialysis patients to lead a more full and active life while adding another 10 to 16 years to their life expectancy.

The NEPHRON+ project is improving the lives of patients by developing a wearable artificial kidney device.
Credit: Nanodialysis

End stage kidney disease is a global public health problem with an estimated 2.4 million patients on dialysis. The number of new cases is rising (7-8% annually) due to population ageing and increased diabetes prevalence. The NEPHRON+ project is improving the lives of patients by developing a wearable artificial kidney device, enabled with information and communication technologies for remote monitoring. Chronic kidney disease will affect one in ten of us at some point in our lives. For those of us unlucky enough to suffer renal failure as a result, the health consequences can be disastrous.

Related Articles


Without treatment kidney failure is deadly. However, even the best treatments are not ideal. Patients have to be treated with a dialysis machine at home or in hospital, sometimes as often as once every four hours. Patients spend a large part of their lives connected to dialysis equipment. What's more, the life expectancy of a person in their 20s who has suffered kidney failure is just 20 years, unless they're lucky enough to receive a donated organ.

All this could change, however. An EU-funded research consortium has been developing a wearable artificial kidney that would make it possible for dialysis patients to lead a more full and active life while adding another 10 to 16 years to their life expectancy.

The future of wearable dialysis

The NEPHRON+ WAKD (Wearable Artificial Kidney Device) is currently undergoing animal trials and will have to pass several rounds of stringent tests in humans before it is ready to be used by all patients with kidney disease. However, the project has reached a stage where commercial partners are ready to take the technology to the next stage. With kidney failure rates on the rise and pressure on hospitals to find more cost effective and clinically effective treatments, the market for wearable dialysis devices could be worth as much as a €15 billion per year, according to Dr Leonidas Lymberopoulos, project coordinator.

The advantages of wearable dialysis

The NEPHRON+ system works like a conventional dialysis machine, taking the patient's blood and passes it through a number of filters, removing waste products that would be excreted in a healthy patient's urine and making sure that the patient's blood pressure stays at a safe level. The patient can see the monitored data via their smartphone. What's more, the data can be sent to the patient's specialist doctor, so that their condition can be monitored at all times. But the wearable device will reduce the chance that a patient has to go to hospital for emergency treatment as constant dialysis is much more effective than intermittent treatment.

Frank Simonis, technical manager of NEPHRON+ explains: "Continuous, 24/7 dialysis with a wearable device offers a smooth and uniform extraction of toxins over the day similar to the natural kidney. This improves the health condition tremendously and eliminates the 'after dialysis sickness syndrome' that many patients suffer from."

Dr Lymberopoulos suggests that the cost of caring for a patient with kidney disease will fall due to the reduction in the need for prescription medicine, nursing staff and installation costs. Cost savings in medical care are expected to €15.000-20.000/patient/year. With 340.000 patients in Europe this implies an annual saving of €5-7 billion.Most importantly, explains Ms Anastasia Garbi, former project leader, "the patient can now lead a more normal life, working and exercising without the regular long visits to the hemodialysis centers."


Story Source:

The above story is based on materials provided by European Commission, CORDIS. Note: Materials may be edited for content and length.


Cite This Page:

European Commission, CORDIS. "Patients with kidney failure to get a new lease on life." ScienceDaily. ScienceDaily, 14 April 2014. <www.sciencedaily.com/releases/2014/04/140414123651.htm>.
European Commission, CORDIS. (2014, April 14). Patients with kidney failure to get a new lease on life. ScienceDaily. Retrieved November 26, 2014 from www.sciencedaily.com/releases/2014/04/140414123651.htm
European Commission, CORDIS. "Patients with kidney failure to get a new lease on life." ScienceDaily. www.sciencedaily.com/releases/2014/04/140414123651.htm (accessed November 26, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, November 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins